Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     infertility Treatment     In Vitro Diagnostics     Immunoassay     Radioimmunoassays (RIA)    
Real Time Market Research & Industry Analysis - MicroMarketMonitor

Asian Radioimmunoassay Market: By Type (Reagents & kits and Analyzers,), By Application (Research, Clinical Diagnostics), By End-User (Hospitals, Pharmaceutical Industry and CROs, Academics and Clinical Diagnostics Laboratories), and By geography -Analysis & Forecast to 2020

  • Report Code: RA 1002
  • Publish Date: Upcoming
  
Description
Table of Contents
Customer Intelligence
Summary
Inquiry Before Buying Ask for Discount

The Asian Radioimmunoassay market is estimated to grow at a CAGR of 4.5% from 2015 to 2020 where China have the largest market share followed by Japan , India , Republic of Korea and Rest of Asia.

 

In this report, the Asian Radioimmunoassay market has been broadly classified on the basis of types, applications, end-users, and geography. On the basis of types, the market is divided into; Reagents & kits and Analyzers which are studied in detail.

 

The application segment is categorized into; Research and Clinical where Clinical Diagnostics has the largest market share of 65.7% in 2014 followed by Research which is increasing at the rate of 4.2% during the forecast year. The end-user includes Hospitals, Pharmaceutical Industry and CROs, Academics and Clinical Diagnostics Laboratories.

 

Analyzers is the fastest growing segment which is estimated to grow at the highest CAGR of 4.7% from 2015 to 2020. Factors such as, aging population, increasing use of Radioimmunoassay in Oncology are driving the growth of this market.

 

The Asian Radioimmunoassay market is a competitive market with a number of market players. As of 2014, the Asian Radioimmunoassay market is majorly dominated by Beckman Coulter, Inc. (U.S.), IBL International (A Tecan Company) (Germany), PerkinElmer, Inc. (U.S.), DRG International, Inc. (U.S.), MP Biomedicals, LLC (U.S.), Cisbio (France), Euro Diagnostica AB (Sweden), among others. New product launches and partnerships, agreements, collaborations, and joint ventures are the major strategies adopted by most market players to achieve growth in the Asian Radioimmunoassay market.    

 

Reasons to Buy the Report:  

From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends, and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging- and high-growth segments of the Asian Radioimmunoassay market, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.  

 

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.

 

The report provides insights on the following pointers:

 

  • Market Penetration: Comprehensive information on Radioimmunoassay products offered by the top players in the Asian Radioimmunoassay market  

 

  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the Radioimmunoassay market  

 

  • Market Development: Comprehensive information about lucrative emerging markets. The report analyses the markets for various Radioimmunoassay technologies across major geographies

 

  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Radioimmunoassay market

 

  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the Asian Radioimmunoassay market


1 Introduction
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)

 

2 Executive Summary
 

3 Market Overview

Please fill in the form below to receive a free copy of the Summary of this Report
















Asian Radioimmunoassay Market: By Type (Reagents & kits and Analyzers,), By Application (Research, Clinical Diagnostics), By End-User (Hospitals, Pharmaceutical Industry and CROs, Academics and Clinical Diagnostics Laboratories), and By geography -Analysis & Forecast to 2020

* Enter the text from the image to the text box :

refresh captcha
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE PUBLISHED
Europe Immunoassay Europe Immunoassay
Europe holds second largest market position in Global Immunoassay Market. Germany commanded the largest share 20% of the European immunoassay market at an estimated $790.6 million in 2013 and is expected to reach $1066.7 million by 2018, at a CAGR of 6.5% from 2013 to 2018. The report “European Immunoassay Market forecast for 2018 “analyzes the market by two segments such as reagents and end instruments.
Upcoming
North America Immunoassay North America Immunoassay
The Americas commanded the largest share 42% of the Global Immunoassay market at an estimated $5248.2 million in 2013 and are expected to reach $7563.2 million by 2018, at a CAGR of 8% from 2013 to 2018. The report “North American Immunoassay Market forecast for 2018 “analyzes the market by two segments such as reagents and end instruments.
Upcoming
Asia Immunoassay Asia Immunoassay
Asian immunoassay market is growing in double digit and will continue to grow in future. China commanded the largest share 53% of the Asian immunoassay market at an estimated $626.0 million in 2013 and is expected to reach $1309.0 million by 2018, at a CAGR of 16.7% from 2013 to 2018. The report “Asian Immunoassay Market forecast for 2018 “analyzes the market by two segments such as reagents and end instruments.
Upcoming
of items
reports | Show
Connect With Us
US/CAN : +1-888-502-0539